The high P/E ratio, despite not impacting the firm's valuation significantly, may risk stock price drop due to inferior growth projection. Investors could be disappointed if P/E aligns with growth, suggesting possible overvaluation.
$Walvax Biotechnology (300142.SZ)$After the midday crash, I called Watson again and got some feedback: 1. Foreign phase iii, will start playing soon. We've been saying we're not fighting, but now we're saying we're fighting. 2. The second phase of the domestic has been played down, specific whether there are adverse reactions, the other party to see the test data. But the other party said that their colleague had been inactivated, and some adverse reactions were also many, such as vomiting and diarrhea. Today's big drop may be a collective kill for the so-called track stocks. Good stocks will soon come back. ...
1
Report
Meltyy
:
The bottom line of the price I can accept is constantly being refreshed
$Walvax Biotechnology (300142.SZ)$Massage for you, this time purely because of a large amount of irregular leverage around the financing plate, the company itself has no problem. If there's a problem, just go to the button. It's impossible to ship. Have you ever seen a ship like this? . Illegal financing dish run out of panic, a few days on the good. The amount of days are taken or very good that is still low valuation. Hold it!
$Walvax Biotechnology (300142.SZ)$Beautiful a Yang line, said last week, more than in 85, is a platform on the larger pressure area, a few times were hard, just last week with breakthrough today is very good, the first to shake out chips last week, either with high or outs, 85 to 93 the position of the second began to digest sewer line, the basic short-term will not be on the back, the main up to start, Do not get off casually, should start from tomorrow, there is back to step on the adjustment of the day, do not get off easily, help steady sit well ...
Bahrain published the actual use comparison results of Pfizer mRNA vaccine and inactivated vaccine of national medicine: To prevent infection, Pfizer effective rate 79%, Chinese medicine 45%; Prevention of hospitalization, Pfizer effective rate of 94%, Chinese medicine 44%; The effective rate of Pfizer was 99% and sinopharm 64%. Prevent death, Pfizer effective rate 95%, 63%.)$Walvax Biotechnology (300142.SZ)$$Shenzhen Kangtai Biological Products (300601.SZ)$
$Moderna (MRNA.US)$$Walvax Biotechnology (300142.SZ)$ [AIDS vaccine enters human experimental stage] ▲Moderna AIDS vaccine will start human trials on August 19 and is expected to be completed in the spring of 2023, using mRNA technology similar to the new crown vaccine. ▲Moderna has two candidate HIV vaccines, mRNA-1644 and mRNA-1644v2-Core. These two vaccines have passed preliminary safety tests before they were first used in humans. ▲The new crown epidemic has accelerated the maturity of mRNA vaccine technology, and this technology is also a technology that can achieve mass production as soon as possible. Several other companies are also developing AIDS vaccines. Some candidate vaccines are currently or are about to enter clinical trials. Looking forward to Watson's breakthroughs in other infectious diseases, just do international mRNA fast-follow. ...
Winn Winn
:
mRNA is a new industry. It may help humans overcome diseases in the future, and in terms of vaccines, to deal with COVID-19, which mutates so fast, only mRNA is strong enough and fast enough
Walvax Biotechnology CO., LTD says the company‘s chimpanzee adenovirus-based COVID19 vaccine is allowed to be applied in emergency clinical tests. The firm has cooperated with Tsinghua University and Tianjin Medical University. $Walvax Biotechnology (300142.SZ)$
Walvax Biotechnology Stock Forum
$Sinovac Biotech (SVA.US)$ $FOSUN PHARMA (02196.HK)$ $Shanghai Fosun Pharmaceutical (600196.SH)$ $CanSino Biologics Inc. (688185.SH)$ $CANSINOBIO (06185.HK)$ $Walvax Biotechnology (300142.SZ)$ $Chongqing Zhifei Biological Products (300122.SZ)$
1. Foreign phase iii, will start playing soon. We've been saying we're not fighting, but now we're saying we're fighting.
2. The second phase of the domestic has been played down, specific whether there are adverse reactions, the other party to see the test data. But the other party said that their colleague had been inactivated, and some adverse reactions were also many, such as vomiting and diarrhea.
Today's big drop may be a collective kill for the so-called track stocks. Good stocks will soon come back.
...
...
To prevent infection, Pfizer effective rate 79%, Chinese medicine 45%;
Prevention of hospitalization, Pfizer effective rate of 94%, Chinese medicine 44%;
The effective rate of Pfizer was 99% and sinopharm 64%.
Prevent death, Pfizer effective rate 95%, 63%.) $Walvax Biotechnology (300142.SZ)$ $Shenzhen Kangtai Biological Products (300601.SZ)$
[AIDS vaccine enters human experimental stage]
▲Moderna AIDS vaccine will start human trials on August 19 and is expected to be completed in the spring of 2023, using mRNA technology similar to the new crown vaccine.
▲Moderna has two candidate HIV vaccines, mRNA-1644 and mRNA-1644v2-Core. These two vaccines have passed preliminary safety tests before they were first used in humans.
▲The new crown epidemic has accelerated the maturity of mRNA vaccine technology, and this technology is also a technology that can achieve mass production as soon as possible. Several other companies are also developing AIDS vaccines. Some candidate vaccines are currently or are about to enter clinical trials.
Looking forward to Watson's breakthroughs in other infectious diseases, just do international mRNA fast-follow.
...
The firm has cooperated with Tsinghua University and Tianjin Medical University.
$Walvax Biotechnology (300142.SZ)$
No comment yet